Skip to main content
Clinical Trials/NCT02040662
NCT02040662
Completed
Phase 2

Comparison of Continuous Epidural and Continuous Paravertebral Blockade in Postoperative Analgesia After Videothoracoscopic Lung Lobectomy

Pulmonary Hospital Zakopane1 site in 1 country120 target enrollmentJanuary 2013
ConditionsLung Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Pulmonary Hospital Zakopane
Enrollment
120
Locations
1
Primary Endpoint
pain intensity measured in VAS in predetermined time intervals after the operation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Thoracic surgery correlates with significant pain in postoperative period. In order to alleviate the pain various combinations of pharmaceuticals and administration methods are employed. So as to reduce the extent of surgical trauma and, consequently, correlated pain various operation techniques are used. In traditional thoracotomy epidural anesthesia remains a golden standard. Epidural anesthesia however demands high skills to be performed correctly and presents an increased risk of grave complications. In videothoracoscopic (VATS) operations paravertebral blockade can be employed, yet there is no certainty if its efficacy after lung lobectomy. We therefore designed a prospective, randomized, parallel group, single site study to test the hypothesis, that continuous paravertebral blockade is as efficient in postoperative pain reduction as continuous epidural blockade and possesses a higher safety profile.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
July 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pulmonary Hospital Zakopane
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status 1-3
  • undergo videothoracoscopic lung lobectomy
  • forced expiratory volume in 1 second (FEV1) \>1,5 l/min
  • no contraindications for epidural anesthesia and paravertebral nerve blockade
  • ability to comprehend principles of VAS pain examination method and to communicate in accordance with them.

Exclusion Criteria

  • prior to the study: contraindications for local anesthesia, ASA\>3, FEV1\<1,5 l/min, conditions disabling the patient from comprehending the principles of VAS pain examination, known allergy to used medications.
  • during the study: failure to place epidural or paravertebral catheter, decision to abandon lobar resection (e.g. in case of neoplastic dissemination), intraoperative conversion to thoracotomy, intraoperative anatomical obstacles to distribution of local anesthetics, conditions disabling the patient from pain evaluation by means of VAS method (e.g. postoperative delirium), necessity to administer other pharmaceuticals influencing pain perception (e.g. sedatives), necessity of mechanical ventilation, interruption of local anesthesia as a result of technical problems (e.g. damage or slippage of catheter).

Outcomes

Primary Outcomes

pain intensity measured in VAS in predetermined time intervals after the operation

Time Frame: up to 96 hrs after the surgery

Secondary Outcomes

  • frequency of respiratory complications: atelectasis or pneumonia(up to 96 hrs after surgery)
  • cumulative opioid (morphine) consumption(up to 96 hrs after surgery)
  • respiratory parameters indirectly indicating conditions for efficient cough: peak expiratory flow (PEF), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC)(up to 96 hrs after the surgery)
  • frequency of side effects of regional anesthesia: urine retention resulting in necessity of bladder catheterization, hypotension, respiratory depression(up to 96 hrs after surgery)

Study Sites (1)

Loading locations...

Similar Trials